Literature DB >> 30799567

Clinical and MRI Characteristics of Uterine Cervical Adenocarcinoma: Its Variants and Mimics.

Tsukasa Saida1, Akiko Sakata2, Yumiko Oishi Tanaka3, Hiroyuki Ochi4, Toshitaka Ishiguro5, Masafumi Sakai5, Hiroaki Takahashi5, Toyomi Satoh4, Manabu Minami5.   

Abstract

Adenocarcinoma currently accounts for 10-25% of all uterine cervical carcinomas and has a variety of histopathological subtypes. Among them, mucinous carcinoma gastric type is not associated with high-risk human papillomavirus (HPV) infection and a poor prognosis, while villoglandular carcinoma has an association with high-risk HPV infection and a good prognosis. They show relatively characteristic imaging findings which can be suggested by magnetic resonance imaging (MRI), though the former is sometimes difficult to be distinguished from lobular endocervical glandular hyperplasia. Various kinds of other tumors including squamous cell carcinoma should be also differentiated on MRI, while it is currently difficult to distinguish them on MRI, and HPV screening and pathological confirmation are usually necessary for definite diagnosis and further patient management.
Copyright © 2019 The Korean Society of Radiology.

Entities:  

Keywords:  Adenocarcinoma; Cervical cancer; Human papillomavirus; MRI; Uterus

Mesh:

Year:  2019        PMID: 30799567      PMCID: PMC6389813          DOI: 10.3348/kjr.2018.0458

Source DB:  PubMed          Journal:  Korean J Radiol        ISSN: 1229-6929            Impact factor:   3.500


INTRODUCTION

Adenocarcinoma currently accounts for 10–25% of all uterine cervical carcinomas in developed countries (1), and its incidence just keeps increasing according to a decrease in the incidence of squamous cell carcinoma (SCC) as a result of improved screening programs (123). Recent studies suggest that high-risk human papillomavirus (HPV) types 16, 18, and 45 are responsible for approximately 70% SCCs and 80% adenocarcinomas (Table 1) (145). The overall prognosis of adenocarcinomas is similar to or slightly poorer than that of SCC; however, the prognosis of each adenocarcinoma varies with its histopathological type (1234567).
Table 1

Correlations of Different Uterine Cervical Tumorous Lesions with High-Risk HPV Infection

AdenocarcinomaHPV Infection
Endocervical adenocarcinoma, usual type+
Mucinous carcinoma
 GAS
 Intestinal type+
 Signet-ring cell type+/-
VGC+
Endometrioid carcinoma
Clear cell carcinoma
Serous carcinoma
Mesonephric carcinoma
Adenocarcinoma admixed with neuroendocrine tumor+

GAS = mucinous carcinoma gastric type, HPV = human papillomavirus, LEGH = lobular endocervical glandular hyperplasia, VGC = villoglandular carcinoma

Cervical tumor is evaluated by several imaging modalities, and it has been reported that SCC tended to be hypoechoic and adenocarcinoma tended to be isoechoic on ultrasound (8), and there was no significant difference in standardized uptake value max between SCC and non-SCC on 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (9). Computed tomography (CT) is limited by poor soft tissue contrast, and magnetic resonance imaging (MRI) is superior to CT for local evaluation (10). Some types of adenocarcinomas show characteristic imaging findings, and the histopathological type can be suggested using MRI. The MRI findings of a variety of cervical tumors can be grossly classified into five patterns (Fig. 1): Type 1, multicystic, or solid and cystic pattern; Type 2, exophytic villous pattern; Type 3, expansile solid pattern; Type 4, invasive solid pattern; and Type 5, diffuse infiltrative pattern. Some mainly show any one of these typical imaging patterns, while others can show mixed patterns.
Fig. 1

MRI patterns of different cervical tumors.

ASC = adenosquamous carcinoma, GAS = mucinous carcinoma gastric type, MRI = magnetic resonance imaging, NET = neuroendocrine tumor, SCC = squamous cell carcinoma, VGC = villoglandular carcinoma

The purpose of this review is to discuss cervical adenocarcinomas and cervical lesions other than SCC from various aspects, including their association with high-risk HPV infection and their prognosis, and to demonstrate their representative MRI findings and patterns.

Cervical Adenocarcinoma

Endocervical Adenocarcinoma, Usual Type (Figs. 2, 3)

This is an invasive epithelial tumor showing glandular differentiation with relative mucin depletion. It is the most common type of cervical adenocarcinoma and accounts for approximately 90% of all adenocarcinomas. It is associated with high-risk HPV infection (Table 1) (145) and, potentially, long-term oral contraceptive use. The mean age at presentation is around 50 years (1). The prognosis of the usual type adenocarcinoma is similar to that of SCC (1234567). Macroscopically, approximately 50% tumors show an invasive growth pattern with an exophytic protrusion, and some show surface ulceration or a diffuse infiltrative pattern. Mucin-poor glands with cribriform and papillary structures are most often seen in histopathological analysis. Occasionally, cervical intraepithelial neoplasia (CIN) or adenocarcinoma in situ (AIS) coexists with this tumor, although they are frequently difficult to be detected radiologically. An invasive solid pattern or a diffuse infiltrative pattern is commonly observed on MRI (Fig. 1; Types 4, 5), and it is generally difficult to distinguish these tumors from SCC using MRI alone. Sometimes, intratumoral cysts can be seen, but these are not common (11). The incidence of ovarian metastasis is higher with this type of adenocarcinoma than with SCC (12).

Mucinous Carcinoma, Gastric Type (Figs. 4, 5)

This is a mucinous adenocarcinoma that shows gastric type differentiation. Mucinous carcinoma gastric type (GAS) accounts for approximately 25% of all adenocarcinomas. GAS is not associated with high-risk HPV infection (Table 1), so its incidence threatens to increase despite improved screening programs. The mean age at presentation is approximately 42 years and its prognosis is poorer than that of the usual type adenocarcinoma. The 5-year disease-free survival rate is 30%, which is much lower than that of the usual type adenocarcinoma (74%) (14). Its association with Peutz-Jeghers syndrome has been noted (14). GAS includes minimal deviation adenocarcinoma (adenoma malignum). In addition, lobular endocervical glandular hyperplasia (LEGH), which is described later, is considered a precursor lesion of GAS according to recent studies (1413). Immunohistochemical studies are positive for makers of pyloric gland mucins (eg., MUC6, HIK1083) (4). GAS typically appears as a multicystic lesion indicating LEGH with inner solid components on MRI, namely a solid and cystic pattern (Fig. 1; Type 1). Diffuse, solid low T2-weighted signal intensities with an unclear margin in LEGH, or a solid component with restricted diffusion in LEGH, suggests an occurrence of GAS (1113); however, sometimes, solid components are small, lack of restricted diffusion, and are difficult to distinguish from LEGH (13). In addition, tumors often diffusely infiltrate and invade more widely than expected on MRI.

Mucinous Carcinoma, Intestinal Type (Fig. 6)

This is a mucinous adenocarcinoma that shows area of intestinal-type differentiation. It accounts for about 2% of all cervical adenocarcinoma s and is associated with high-risk HPV infection (Table 1). Occasionally, the usual type adenocarcinoma coexists with this tumor depending on its association with high-risk HPV infection (14). The intestinal differentiation shows typical mucinous-type epithelium and the most important differential diagnosis is metastasis from intestinal carcinoma. Immunohistochemical studies are positive for makers of intestinal mucins (e.g., CDX2) (4). An invasive solid pattern or a diffuse infiltrative pattern is commonly observed on MRI (Fig. 1; Types 4, 5), and it generally shows relatively high signal intensities on T2-weighted imaging (T2WI) and weak restricted diffusion reflecting intracellular mucinous components (14).

Villoglandular Carcinoma (Fig. 7)

This is a variant of endocervical adenocarcinoma that shows a distinct exophytic, villous-papillary growth. It accounts for 3.7–4.8% of all cervical adenocarcinomas, and associated with high-risk HPV infection (Table 1). It affects younger individuals, and the mean age at presentation is approximately 35 years (14). It has a good prognosis and fertility-preserving surgery may be considered if the tumor is in the early stage (115). Occasionally, CIN or AIS coexists with this tumor depending on its association with high-risk HPV infection (1). A fern leaf-like appearance, i.e., an exophytic villous pattern (Fig. 1; Type 2), with restricted diffusion is a typical MRI finding of villoglandular carcinoma (VGC) (16).

Clear Cell Carcinoma (Fig. 8)

This adenocarcinoma is predominantly composed of clear or hobnail cells with solid, tubulocystic, and/or papillary architectural patterns. Microscopically, a solid tumor typically contains abundant glycogen-rich cytoplasm. It accounts for 2–4% of all cervical adenocarcinomas, and not associated with high-risk HPV infection (Table 1) (45). In utero diethylstilbestrol exposure causes clear cell carcinoma in young patients with an average age of 19 years. However, the tumor now becomes rare, and most cases are sporadic and involve older patients with an average age of 47 years (1). Clear cell carcinoma is clinically similar to the usual type adenocarcinoma, and its prognosis is also similar to that of the usual type adenocarcinoma (1). It is difficult to distinguish clear cell carcinoma from SCC and the usual type adenocarcinoma using MRI alone (Fig. 1).

Endometrioid Carcinoma (Fig. 9)

This adenocarcinoma arises in the cervix and exhibits endometrioid morphological features (1) and is not associated with high-risk HPV infection (Table 1) (45). It is clinically and macroscopically similar to the usual type adenocarcinoma, and some researchers suggest that it is just a morphological variant of the usual type adenocarcinoma (1). Usually, it is difficult to distinguish endometrioid carcinoma from SCC and the usual type adenocarcinoma using MRI alone (Fig. 1). Moreover, the most important differential diagnosis is corpus endometrioid carcinoma extending to the cervix, which can be clinically misdiagnosed as cervical endometrioid carcinoma (1).

Other Cervical Tumors and Tumor-Like Lesions

Lobular Endocervical Glandular Hyperplasia (Fig. 10)

This is a distinct benign lobular proliferation of endocervical glands that commonly exhibits gastric/pyloric differentiation. Pyloric gland metaplasia is a synonym for LEGH. LEGH is considered a potential precursor lesion of GAS, and GAS or AIS occasionally coexists in LEGH lesions, necessitating careful attention in diagnosis. It may occur in women of reproductive age or postmenopausal women and watery or mucoid discharge is a characteristic clinical manifestation (1). Typically, it is located in the upper cervical canal. MRI findings of LEGH show two patterns, a cosmos pattern and a microcystic pattern. The cosmos pattern is characterized by central microcystic components surrounded by medium-sized to large cysts, while the microcystic pattern is characterized by the aggregation of small cysts without peripheral larger cysts. LEGH, particularly the microcystic pattern type, may be sometimes difficult to distinguish from GAS or AIS using MRI alone (13). In addition, other cystic lesions need to be differentiated from LEGH, such as Nabothian cyst, tunnel cluster, and endocervical polyp (1317), all of which are categorized as benign glandular tumors and tumor-like lesions in the fourth edition of the World Health Organization (WHO) classification and not associated with high-risk HPV infection (Table 1) (1).

Nabothian Cyst (Fig. 11)

This is a cystic structure in the cervical wall that is lined by normal endocervical epithelium and filled with mucus. A Nabothian cyst is a common finding, particularly in multiparous women (1). It is usually asymptomatic and often found incidentally on MRI. These cysts may be single or multiple, and they usually measure 2–10 cm in diameter. Generally, they are located near the surface of the endocervical canal, but they are occasionally found deep in the endocervical wall (1). The cyst is filled with mucus and characteristically exhibits high to intermediate signal intensities on T2WI and intermediate or slightly high signal intensities on T1-weighted imaging (17).

Endocervical Polyp (Fig. 12)

This is an exophytic lesion lined by benign endocervical epithelium covering a fibrovascular core. Sometimes a focus of in situ or invasive carcinoma can be contained within an endocervical polyp. It is one of the most common causes of intermenstrual vaginal bleeding (1). A multicystic structure with a fibrovascular core is a characteristic MRI finding (17).

Adenosquamous Carcinoma (Fig. 13)

This is a malignant tumor having both adenocarcinoma and SCC components, and the adenocarcinoma component should be adequately differentiated on the basis of histologically recognizable glands. Adenosquamous carcinoma (ASC) accounts for 3.6% of all cervical carcinomas, and usually be associated with high-risk HPV infection (Table 1) (418). The mean age at presentation is approximately 50 years (6). Some studies have suggested a poorer prognosis than that of SCC and the usual type adenocarcinoma (467). It is generally difficult to distinguish this entity from SCC and the usual type adenocarcinoma using MRI alone (Fig. 1).

Neuroendocrine Tumor (Fig. 14)

This tumor is similar to gastro-entero-pancreatic neuroendocrine tumors (NETs) and is divided into high-grade and low-grade types. High-grade NETs are composed of high-grade malignant cells and may be either the small cell type or the large cell type. NETs are associated with high-risk HPV infection (Table 1), and may be accompanied by in situ or invasive SCC or adenocarcinoma. High-grade NETs are very aggressive, often accompanied by lymph node and distant metastasis and indicate a poor prognosis (1920). MRI findings widely vary from the expansile solid pattern and the invasive solid pattern to the diffuse infiltrative pattern (Fig. 1; Types 3–5). Cervical NETs tend to appear as homogeneous lesions with multiple lymphadenopathies and are associated with a low apparent diffusion coefficient (ADC) (1721).

Leiomyoma (Fig. 15)

This is a benign tumor showing smooth muscle differentiation and containing a variable amount of collagen-rich extracellular matrix. It is categorized as a mesenchymal tumor and tumor-like lesion in the fourth edition of the WHO classification and not associated with high-risk HPV infection (Table 1) (1). Cervical leiomyoma is much rarer than leiomyoma involving the uterine body, and its frequency has been estimated to be 0.6% in hysterectomy specimens (22). The lesion shows an expansile solid pattern (Fig. 1; Type 3) on MRI and typically appears as a well-defined, homogeneous, hypointense mass in the cervical stroma on T2WI, without restriction on diffusion-weighted imaging (DWI) (172324).

Leiomyosarcoma (Fig. 16)

This is a malignant tumor showing smooth muscle differentiation. Primary sarcomas account for less than 1% of all malignant cervical tumors, and leiomyosarcoma is the most common type (22) and not associated with high-risk HPV infection (Table 1) (1). MRI shows an expansile solid pattern or an invasive solid pattern (Fig. 1; Types 3, 4). Leiomyosarcoma tends to show relatively high intensities on T2WI and restriction on DWI. Hemorrhage or necrosis and invasion of surrounding structures may be seen; these findings suggest leiomyosarcoma rather than leiomyoma (172324).

Lymphoma (Fig. 17)

Primary or secondary lymphoma is a malignant neoplasm composed of lymphoid cells without association of high-risk HPV infection (Table 1) (1). Uterine involvement is uncommon and primary lymphoma is much rarer. The majority of primary uterine lymphomas are B-cell lymphomas. The primary lesions commonly involve the cervix and usually respond well to chemotherapy and radiotherapy and exhibit a favorable prognosis, while the secondary lesions involve either the corpus or the cervix and has worse prognosis (2526). MRI findings widely vary from an expansile solid pattern and an invasive solid pattern to a diffuse infiltrative pattern (Fig. 1; Types 3–5). Generally, diffuse enhancement and low ADC values are observed (1727).

Secondary Tumors (Fig. 18)

Malignancies arising from structures surrounding the cervix, such as the uterine body, bladder, ureter, rectum, and ovary, can be misdiagnosed as primary uterine cervical cancer because of uterine cervix involvement (28). MRI is a useful tool for distinguishing secondary cervical tumors from the primary ones. In summary, uterine cervical adenocarcinoma has a variety of histopathological subtypes. Among them, GAS and VGC show relatively characteristic imaging findings, and their histological types can be suggested using MRI. GAS is not associated with high-risk HPV infection, and its incidence threatens to increase. It exhibits a poor prognosis and should be distinguished from LEGH, though this differentiation can be sometimes difficult by MRI alone. VGC, on the other hand, has an association with high-risk HPV infection and a good prognosis compared with SCC and the usual type adenocarcinoma. Various kinds of other tumors should be also differentiated on MRI, while it is currently difficult to distinguish them and HPV screening and pathological confirmation are usually necessary for definite diagnosis and further patient management.
  21 in total

1.  Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study.

Authors:  Donald G Mitchell; Bradley Snyder; Fergus Coakley; Caroline Reinhold; Gillian Thomas; Marco Amendola; Lawrence H Schwartz; Paula Woodward; Harpreet Pannu; Hedvig Hricak
Journal:  J Clin Oncol       Date:  2006-12-20       Impact factor: 44.544

2.  Ovarian metastasis in carcinoma of the uterine cervix.

Authors:  Muneaki Shimada; Junzo Kigawa; Ryuichiro Nishimura; Satoshi Yamaguchi; Kazuo Kuzuya; Toru Nakanishi; Mitsuaki Suzuki; Tsunekazu Kita; Tsuyoshi Iwasaka; Naoki Terakawa
Journal:  Gynecol Oncol       Date:  2005-11-21       Impact factor: 5.482

3.  Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10).

Authors:  Jae Myoung Noh; Won Park; Young Seok Kim; Joo-Young Kim; Hak Jae Kim; Juree Kim; Jin Hee Kim; Mee Sun Yoon; Jin Hwa Choi; Won Sup Yoon; Ji-Yoon Kim; Seung Jae Huh
Journal:  Gynecol Oncol       Date:  2014-01-31       Impact factor: 5.482

Review 4.  Magnetic resonance imaging of primary lymphoma of the cervix.

Authors:  Carlos Marín; José M Seoane; Marisa Sánchez; Yolanda Ruiz; José A García
Journal:  Eur Radiol       Date:  2001-11-21       Impact factor: 5.315

5.  Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings.

Authors:  Yumiko Oishi Tanaka; Masato Nishida; Hajime Tsunoda; Yoshikazu Okamoto; Hiroyuki Yoshikawa
Journal:  J Magn Reson Imaging       Date:  2004-12       Impact factor: 4.813

Review 6.  MR imaging of the uterine cervix: imaging-pathologic correlation.

Authors:  Yoshikazu Okamoto; Yumiko O Tanaka; Masato Nishida; Hajime Tsunoda; Hiroyuki Yoshikawa; Yuji Itai
Journal:  Radiographics       Date:  2003 Mar-Apr       Impact factor: 5.333

7.  Clinical application of diffusion-weighted imaging for preoperative differentiation between uterine leiomyoma and leiomyosarcoma.

Authors:  Kenichiro Sato; Noriaki Yuasa; Miri Fujita; Yasuyoshi Fukushima
Journal:  Am J Obstet Gynecol       Date:  2013-12-22       Impact factor: 8.661

8.  A retrospective review of 11 cases of villoglandular papillary adenocarcinoma of the uterine cervix and a review of the literature.

Authors:  Liping Zhao; Tianmin Xu; Manhua Cui; Zeming Fu
Journal:  Oncol Lett       Date:  2016-02-01       Impact factor: 2.967

Review 9.  Opportunities for 2-[(18)F] fluoro-2-deoxy-D-glucose PET/CT in cervical-vaginal neuroendocrine carcinoma: case series and literature review.

Authors:  Yin Lin; Wan Y Lin; Ji A Liang; Yu Y Lu; Hsin Y Wang; Shih C Tsai; Chia H Kao
Journal:  Korean J Radiol       Date:  2012-10-12       Impact factor: 3.500

10.  Usefulness of a management protocol for patients with cervical multicystic lesions: A retrospective analysis of 94 cases and the significance of GNAS mutation.

Authors:  Hirofumi Ando; Tsutomu Miyamoto; Hiroyasu Kashima; Akiko Takatsu; Keiko Ishii; Yasunari Fujinaga; Tanri Shiozawa
Journal:  J Obstet Gynaecol Res       Date:  2016-10-08       Impact factor: 1.730

View more
  10 in total

1.  Screening of prognostic immune genes and establishment of prognostic model of cervical adenocarcinoma based on bioinformatics analysis.

Authors:  Yunhua Yi; Jiangxin Sheng; Jichan Nie
Journal:  Ann Transl Med       Date:  2022-05

2.  A rare case of gastric-type mucinous endocervical adenocarcinoma in a 59-year-old woman.

Authors:  Francesk Mulita; Fotios Iliopoulos; Ioannis Kehagias
Journal:  Prz Menopauzalny       Date:  2020-10-02

3.  Analysis of Clinicopathological Features of Cervical Mucinous Adenocarcinoma with a Solitary Ovarian Metastatic Mass as the First Manifestation.

Authors:  Shuanghuan Liu; Yunquan Guo; Bin Li; Huijuan Zhang; Rong Zhang; Shan Zheng
Journal:  Cancer Manag Res       Date:  2020-09-24       Impact factor: 3.989

4.  Analysis of quantitative and semi-quantitative parameters of DCE-MRI in differential diagnosis of benign and malignant cervical tumors.

Authors:  Jun Song; Yong Gu; Tingting Du; Qiyu Liu
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

5.  An unusual presentation of usual-type endocervical adenocarcinoma with lobular endocervical glandular hyperplasia: A case report.

Authors:  Yasuteru Sasakura; Tetsuya Katsumori; Osamu Kizu; Hiroko Yomo; Masamichi Bamba
Journal:  Case Rep Womens Health       Date:  2021-02-11

Review 6.  Magnetic Fields and Cancer: Epidemiology, Cellular Biology, and Theranostics.

Authors:  Massimo E Maffei
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

7.  Case Report: Giant Pelvic Cystic Appearance-An Unusual Feature of Uterine Cervical Adenocarcinoma.

Authors:  Yongxin Wang; Xue Shan; Man Li; Ying Yue
Journal:  Front Surg       Date:  2022-03-09

8.  Diagnosis of Early Cervical Cancer with a Multimodal Magnetic Resonance Image under the Artificial Intelligence Algorithm.

Authors:  Zhenge Zhang; Chongyuan Zhang; Li Xiao; Shuirong Zhang
Journal:  Contrast Media Mol Imaging       Date:  2022-03-23       Impact factor: 3.161

9.  Proteomic analysis of human cervical adenocarcinoma mucus to identify potential protein biomarkers.

Authors:  Zhifang Ma; Jie Chen; Ting Luan; Chengzhuo Chu; Wangfei Wu; Yichao Zhu; Yun Gu
Journal:  PeerJ       Date:  2020-07-28       Impact factor: 2.984

10.  Gastric-type endocervical adenocarcinoma with mucoepithelial metaplasia combined with a serous borderline tumor: A case report.

Authors:  Man Yin; Linqing Yang; Yunfei Wang
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.